Rising Research and Development is driving the Lupus Therapeutic Market Growth

 

Lupus Therapeutic Market
Lupus Therapeutic Market

Lupus Therapeutic Market, By Type (Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus, Neonatal Lupus), Treatment (Corticosteroids, Immunosuppressive Drugs, Biologic Drugs, Antihypertensive Drugs, Others), Diagnosis (Laboratory Tests, Biopsy, Imaging Tests, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Lupus Therapeutic Market is estimated to be valued at US$ 2,795.2 million in 2022 and is expected to exhibit a CAGR of 8.6 % over the forecast period as highlighted in a new report published by Coherent Market Insights.

Market Overview

Lupus is an enduring disease in which the body’s resistivity system stops to know its cells and matters as self and starts bellicose them. The four main forms of lupus consist SLE, CLE, MPLE, and NL. SLE is the very usual type of lupus that leads destruction to various organs of the body such as the renal, pneumonic, cardiac, and others. SLE leads to irritation in the dermis, bones, lungs, blood tissues, renal, and others. This condition generally goes from cycles of flare-ups and reductions.

Competitive Landscape:

Key players involved in the growth of global lupus therapeutic market are Sanofi, Aurinia Pharmaceuticals Inc., Bristol-Myers Squibb Company, Hikma Pharmaceuticals PLC, Boehringer Ingelheim International Gmbh, Lupus Therapeutics, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Takeda Pharmaceutical Company Limited, ImmuPharma PLC, Bayer AG,F.Hoffmann-La Roche Ltd, UCB S.A., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, AstraZeneca, ADMA Biologics, Inc., Amgen Inc., Merck & Co., Inc., and Novartis AG.

Market Key Drivers:

Rising research and development activities for the development in new therapies for lupus is expected to augment the growth of global lupus therapeutic market. For instance, in November 2021, AstraZeneca, a U.K. developed biopharma industry announced results from its TULIP Phase III clinical test.

Increasing focus of key players in the expansion of the product is projected to propel the growth of the global lupus therapeutic market. For instance, in December 2020, GlaxoSmithKline plc, a U.K. developed pharma company was approved by U.S. FDA for its medicine BENLYSTA to be used in combination with standard therapy for cure of geriatric people with active LN.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of the global lupus therapeutic market as there was interruption in supply chain, lack of delay in other treatments, interruption in healthcare sector, and restriction on transportation of goods. However, the market was on growth as the Covid-19 treatment was related to people suffering from lupus.

Key Takeaways:

The global lupus therapeutic market is expected to exhibit a CAGR of 8.6 % during the forecast period owing to the rising collaborations and partnerships. For instance, in November 2020, iSD Immunotech, a DBC collaborated with Biogen, a U.S. origin biotech industry for advancement of a patient to be used in the therapy of ADL.

Among regions, North America, Asia Pacific and Europe anticipated to witness robust growth in the global lupus therapeutic market due to increasing cases of lupus, rising collaborations and partnerships, rising approvals and launches of products. For instance, as per WHO, around 1.5 million Americans suffer from a kind of lupus annually in U.S.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techn
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories of a
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C
Read more